Epstein Secrets

parent company to sell 234M shares @ HK$21.53 - 9.7% discount to prior close Gartner Q2 mobile phone market share vs Q2'11: Samsung 21.6% (16.3%), Nokia 19.9% (22.8%), Apple 6.9% (4.6%), ZTE 4.3% (3%), LG 3.4% (5.7%), Huawei 2.6% (2.1%), TCL 2.2% (1.9%), HTC 2.2% (2.6%), Motorola 2.2% (2.4%), RIM 1.

DA & revs inline, raising FY guidance, mainly in Maersk line EFTA00406719 (trading +1.0%) Astrazeneca ups guidance after selling Nexium rights to Pfizer, ups guidance (trading +0.70%) Salzgitter Q2 inline (post profit warning June 26th), leaves outlook unchanged (trading +1.5%) Merck Q2 good beat

s worse off." He adds, "America and its allies also have vulnerabilities." Beijing signaled Monday that it might retaliate by imposing sanctions on Nokia and Ericsson, which depend on some Chinese components." A Chinese diplomat in Europe recently offered a menacing warning: 'We treat our friends with

7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory guidelines." NBC Nightly News

ons worse off" He adds, "America and its allies also have vulnerabilities." Beijing signaled Monday that it might retaliate by imposing sanctions on Nokia and Ericsson, which depend on some Chinese components." A Chinese diplomat in Europe recently offered a menacing warning: `We treat our friends wit

(7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Modema and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory guidelines." NBC Nightly News

maker Allergan FT EFTA00370852 • Freedom to (rack plan faces backlash FT • Nike's FuelBand runs into trouble FT • Microsoft fine-tunes €5.4bn Nokia deal FT • Carmakers put foot down over emissions FT • 'Click and collect' grows at fast rate FT • Recovery 'could let Osborne cut tax by £7bn'

t Animal Health to Lilly for $5.4B (NOVN VX +2.3%, GSK LN +5.3%, LLY no volume) • Astrazeneca ADR's closed +8.8% yesterday on Sunday Times story of Pfizer talks (trading +6.9%) • Philips misses estimates, adjusted EBITA 12% light on HC + lighting, weaker EM & FX (trading -7.0%) • Accor O1 sales miss

s worse off." He adds, "America and its allies also have vulnerabilities." Beijing signaled Monday that it might retaliate by imposing sanctions on Nokia and Ericsson, which depend on some Chinese components." A Chinese diplomat in Europe recently offered a menacing warning: 'We treat our friends with

7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory guidelines." NBC Nightly News

S Korean industrial output FT • WCB: Blessed are the cheesemakers Lex • X-factor: energy bankruptcies Lex • Deutsche Bank: worry beads Lex • Nokia: Finnishing up Lex • Europeans Shared Spy Data With U.S. WSJ • Al Gore and David Blood: The Coming Carbon Asset Bubble WSJ • Facebook Stock's S

STT, TXI, XOOM, HA Shareholder Meetings: DFZ, STX, ONP, XNY Equity/Mixed Shelfs: CAMP, LTD Other Newspaper Articles & Stories Barron's positive: Pfizer (PFE) Barron's WSJ cautious: Sears Holdings (SHLD) WSJ • Shake-up on charges for UK asset managers FT • Day of reckoning as European banks' bill

s worse off." He adds, "America and its allies also have vulnerabilities." Beijing signaled Monday that it might retaliate by imposing sanctions on Nokia and Ericsson, which depend on some Chinese components." A Chinese diplomat in Europe recently offered a menacing warning: `We treat our friends with

7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory guidelines." NBC Nightly News